1Department of Neurosciences, Reproductive and Odontostomatological Sciences, Division of Neurosurgery, University of Naples Federico II, Naples, Italy; and.
2Department of Neurosciences, Reproductive and Odontostomatological Sciences, Division of Ophthalmology, University of Naples Federico II, Naples, Italy.
J Neurosurg. 2023 Sep 29;140(3):696-704. doi: 10.3171/2023.7.JNS23437. Print 2024 Mar 1.
Tuberculum sellae meningioma (TSM) represents a complex skull base tumor. The primary goals of surgical treatment are represented by maximal safe resection and visual recovery; therefore, appropriate patient selection is critical to optimize results. In the last 2 decades, the endoscopic endonasal approach (EEA) has appeared as a successful and viable strategy for the management of these tumors. The authors identified preoperative factors associated with extent of resection and visual outcome after EEA for TSM.
In this retrospective cohort study, the authors analyzed patients who underwent extended endoscopic endonasal surgery for TSM between January 2005 and April 2022 at the Division of Neurosurgery, Università degli Studi di Napoli Federico II, Naples, Italy. Tumor size, vessel encasement, and optic canal involvement were classified according to University of California, San Francisco, score. Visual acuity and visual fields were analyzed according to the visual impairment score (VIS), defined as a four-level classification: grade 1 (VIS 0-25), grade 2 (VIS 26-50), grade 3 (VIS 51-75), and grade 4 (VIS 76-100). Ophthalmological functions were tested preoperatively and during the early postoperative period (within 6 months after surgery) and late postoperative period.
A total of 48 patients were enrolled. Forty-one (85.4%) patients experienced blurred vision or visual field defect as a presenting sign. Gross-total resection was achieved in 40 (83.3%), near-total resection in 2 (4.2%), and subtotal resection in 6 (12.5%). Visual defect improved in 82.9% (34/41) of cases, 12.2% (5/41) had no significant changes, and 2.4% (1/41) had worsened visual defect. The mean change in VIS was 42% (95% CI 58.77-31.23). Visual outcome was poorer when preoperative VIS (VIS-pre) was greater than 25 (p = 0.02). Six postoperative CSF leaks occurred (12.5%), and 1 patient (2.1%) required revision surgery.
The EEA is a safe and effective approach for TSM removal, with the advantage of preserving optic apparatus vascularization, and can promote gross-total resection and visual improvement. The authors have defined four categories based on VIS that relate to postoperative outcome: the lower the VIS-pre, the higher the rate of postoperative VIS improvement. This finding may be useful for predicting a patient's visual outcome at the preoperative stage.
鞍结节脑膜瘤(TSM)是一种复杂的颅底肿瘤。手术治疗的主要目标是实现最大限度的安全切除和视力恢复;因此,适当的患者选择对于优化结果至关重要。在过去的 20 年中,内镜经鼻入路(EEA)已成为治疗这些肿瘤的一种成功且可行的策略。作者确定了与 EEA 治疗 TSM 的切除范围和视力结果相关的术前因素。
在这项回顾性队列研究中,作者分析了 2005 年 1 月至 2022 年 4 月期间在意大利那不勒斯 Federico II 大学神经外科接受扩展内镜经鼻手术治疗 TSM 的患者。根据加利福尼亚大学旧金山分校评分,对肿瘤大小、血管包绕和视神经管受累进行分类。根据视力损害评分(VIS)分析视力和视野,VIS 定义为四级分类:等级 1(VIS 0-25)、等级 2(VIS 26-50)、等级 3(VIS 51-75)和等级 4(VIS 76-100)。术前和术后早期(术后 6 个月内)和晚期测试眼科功能。
共纳入 48 例患者。41 例(85.4%)患者以视力模糊或视野缺损为首发症状。40 例(83.3%)患者实现了大体全切除,2 例(4.2%)实现了近全切除,6 例(12.5%)实现了次全切除。41 例(85.4%)病例的视力缺损得到改善,12.2%(5/41)无明显变化,2.4%(1/41)视力缺损恶化。VIS 的平均变化为 42%(95%CI 58.77-31.23)。术前 VIS(VIS-pre)大于 25 时,视觉预后较差(p=0.02)。术后发生 6 例(12.5%)脑脊液漏,1 例(2.1%)患者需要再次手术。
EEA 是一种安全有效的 TSM 切除方法,其优点是保留视神经血管化,并能促进大体全切除和视力改善。作者根据 VIS 定义了四个类别,与术后结果相关:VIS-pre 越低,术后 VIS 改善率越高。这一发现可能有助于在术前阶段预测患者的视力预后。